Recurrence incidence of small HCC in cirrhosis patients by ablation versus injection
BACKGROUND/AIMS: The incidence of local recurrence of hypervascular hepatocellular carcinoma (HCC) (15 mm or less) was compared retrospectively between a group treated with radiofrequency ablation (RFA) using cool-tip (Radionics, USA) 10-mm electrodes and a group treated with percutaneous ethanol injection (PEI).
METHODOLOGY: There were 23 patients who were treated for a total of 25 tumors during a 3-year period at our hospital. Ten of the tumors (11.1 +/- 2.7mm) were treated with RFA using cool-tip 10-mm electrodes and 15 tumors (10.6 +/- 2.7 mm) were treated with PEI. After treatment, progression was evaluated in enhanced CT scans every 3-6 months to confirm presence or absence of local recurrence.
RESULTS: The number of recurrences, mean observation period, and mean recurrence period in the RFA group were 2 (20%), 6.6 months, and 6 months. The number of recurrences, mean observation period, and mean recurrence period in the PEI group were 2 (13.3%), 19.1 months, and 18 months. The period between treatment and recurrence tended to be longer in the PEI group than in the RFA group to be significant p < 0.05.
CONCLUSIONS: The results suggest that PEI treatment is more effective in local treatment of hypervascular HCC with tumor diameters of 15 mm or less.
Medienart: |
Artikel |
---|
Erscheinungsjahr: |
2010 |
---|---|
Erschienen: |
2010 |
Enthalten in: |
Zur Gesamtaufnahme - volume:57 |
---|---|
Enthalten in: |
Hepato-gastroenterology - 57(2010), 98 vom: 25. März, Seite 195-201 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Wakui, Noritaka [VerfasserIn] |
---|
Themen: |
---|
Anmerkungen: |
Date Completed 13.08.2010 Date Revised 21.11.2013 published: Print Citation Status MEDLINE |
---|
Förderinstitution / Projekttitel: |
|
---|
PPN (Katalog-ID): |
NLM199153140 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM199153140 | ||
003 | DE-627 | ||
005 | 20231223214102.0 | ||
007 | tu | ||
008 | 231223s2010 xx ||||| 00| ||eng c | ||
028 | 5 | 2 | |a pubmed24n0664.xml |
035 | |a (DE-627)NLM199153140 | ||
035 | |a (NLM)20583411 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Wakui, Noritaka |e verfasserin |4 aut | |
245 | 1 | 0 | |a Recurrence incidence of small HCC in cirrhosis patients by ablation versus injection |
264 | 1 | |c 2010 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ohne Hilfsmittel zu benutzen |b n |2 rdamedia | ||
338 | |a Band |b nc |2 rdacarrier | ||
500 | |a Date Completed 13.08.2010 | ||
500 | |a Date Revised 21.11.2013 | ||
500 | |a published: Print | ||
500 | |a Citation Status MEDLINE | ||
520 | |a BACKGROUND/AIMS: The incidence of local recurrence of hypervascular hepatocellular carcinoma (HCC) (15 mm or less) was compared retrospectively between a group treated with radiofrequency ablation (RFA) using cool-tip (Radionics, USA) 10-mm electrodes and a group treated with percutaneous ethanol injection (PEI) | ||
520 | |a METHODOLOGY: There were 23 patients who were treated for a total of 25 tumors during a 3-year period at our hospital. Ten of the tumors (11.1 +/- 2.7mm) were treated with RFA using cool-tip 10-mm electrodes and 15 tumors (10.6 +/- 2.7 mm) were treated with PEI. After treatment, progression was evaluated in enhanced CT scans every 3-6 months to confirm presence or absence of local recurrence | ||
520 | |a RESULTS: The number of recurrences, mean observation period, and mean recurrence period in the RFA group were 2 (20%), 6.6 months, and 6 months. The number of recurrences, mean observation period, and mean recurrence period in the PEI group were 2 (13.3%), 19.1 months, and 18 months. The period between treatment and recurrence tended to be longer in the PEI group than in the RFA group to be significant p < 0.05 | ||
520 | |a CONCLUSIONS: The results suggest that PEI treatment is more effective in local treatment of hypervascular HCC with tumor diameters of 15 mm or less | ||
650 | 4 | |a Comparative Study | |
650 | 4 | |a Journal Article | |
650 | 7 | |a Ethanol |2 NLM | |
650 | 7 | |a 3K9958V90M |2 NLM | |
700 | 1 | |a Iida, Kazunari |e verfasserin |4 aut | |
700 | 1 | |a Ikehara, Takashi |e verfasserin |4 aut | |
700 | 1 | |a Takayama, Ryuji |e verfasserin |4 aut | |
700 | 1 | |a Shiozawa, Kazue |e verfasserin |4 aut | |
700 | 1 | |a Takahashi, Masayoshi |e verfasserin |4 aut | |
700 | 1 | |a Nagai, Hidenari |e verfasserin |4 aut | |
700 | 1 | |a Watanabe, Manabu |e verfasserin |4 aut | |
700 | 1 | |a Ishii, Koji |e verfasserin |4 aut | |
700 | 1 | |a Igarashi, Yoshinori |e verfasserin |4 aut | |
700 | 1 | |a Sumino, Yasukiyo |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Hepato-gastroenterology |d 1993 |g 57(2010), 98 vom: 25. März, Seite 195-201 |w (DE-627)NLM012633151 |x 0172-6390 |7 nnns |
773 | 1 | 8 | |g volume:57 |g year:2010 |g number:98 |g day:25 |g month:03 |g pages:195-201 |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 57 |j 2010 |e 98 |b 25 |c 03 |h 195-201 |